ARTICLE | Distillery Therapeutics
Increasing SOD3 activity for chemo-induced cognitive impairment
November 8, 2022 5:05 PM UTC
Increasing activity of the antioxidant enzyme SOD3 in the choroid plexus could help prevent methotrexate-induced cognitive impairment by decreasing oxidative stress in the CNS. SOD3 levels were lower in CSF samples from methotrexate-treated CNS lymphoma patients than in samples from healthy controls, and levels of metabolites that are hallmarks of oxidative stress were higher in the patient samples. ...
BCIQ Company Profiles
BCIQ Target Profiles